The 2021 Tri-Con Virtual Conference may be over now, but that doesn't mean you have to miss it. Order it now On-Demand!
Celebrating its 28th year, Molecular Medicine Tri-Conference drew more than 1,000 virtual participants!
Molecular Medicine Tri-Con 2021 Highlights
This year the Molecular Med Tri-Conference participants gathered virtually
over 3 days to discuss the latest research and technologies in COVID-19 diagnostics, vaccines and biotherapeutics, point-of-care diagnostics, biomarkers and liquid biopsy, data analytics and artificial intelligence.
The 2021 program offered 8 distinct conferences, and four plenary keynote sessions, focused on advances and innovative solutions in all aspects of molecular & precision medicine, including COVID-19 Vaccines & Biotherapeutics, Circulating
Tumor Cells and Liquid Biopsy, Immuno-Oncology Biomarkers, Point-of-Care Diagnostics, Clinical & Translational Biomarkers and Data, Analytics & AI for Precision Medicine.
The impressive audience at Molecular Medicine Tri-Conference had more than 50% of the attendees titled as a decision-maker from leading Pharma (17%), Biotech companies (50%), and Healthcare
(11%). Industry leaders and key decision-makers representing 28 different countries and more than 450 unique organizations shared case studies, collaborated on best practices, and provided unique perspectives on poignant issues that
the field currently faces.
Mark your calendar for 2022
29th Annual Molecular Medicine Tri-Conference 2022
February 21-23, 2022
(New Location) Hilton San Diego Bayfront / San Diego, California